Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Actinium Announces Actimab-A Plus 7+3 Combination Trial for AML

americanpharmaceuticalreviewMarch 05, 2020

Tag: Actinium , AML , Actimab-A , CD33

PharmaSources Customer Service